For detection of MRD in AML samples using flow cytometry a comprehensive panel of markers is used including early/stem cell markers(CD34 and CD 117) in addition to myeloid lineage and differentiation markers(CD2, CD7, CD19, CD56) to track aberrant AML blasts. Here, CD34 is linked to acute myeloid leukemia.